Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal Failure Hemodialysis Patients

• Status: Completed
• Trial end date: 2021-12-26
• Target enrollment: 0
• Participant gender: All

Summary

To explore the clinical effect of Shenkang Decoction in chronic renal failure (CRF) patients with hemodialysis (HD).

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The First People's Hospital of Zunyi

Criteria

Inclusion Criteria:

• The diagnosis of western medicine meets the diagnostic criteria of chronic kidney failure in Internal Medicine

• the diagnosis of TCM meets the diagnostic criteria of the disease in the Guiding Principles for Clinical Research of New Chinese Medicine.

• The patient is over 18 years old,

• can think independently and have civil conduct,

• strictly follow the doctor's advice,

• maintain stable condition and regular HD treatment.

Exclusion Criteria:

• Patients with HD time of no more than three months, severe uncontrolled infection, other malignant diseases, heart, liver, brain, and digestive system dysfunction, mental diseases such as dementia or depression;

• contraindications to HD or contraindications to the study (Shock or systolic blood pressure below 80mm/Hg, severe bleeding or a tendency to bleed, serious infection such as sepsis, or a blood-borne infection, advanced tumor, extremely debilitating or not cooperating with doctor)

• drug allergy, chronic use of glucocorticoids, and immunosuppressants.

• women during pregnancy or lactation.